MYC and cancer: DDX5 is over-expressed in a variety of cancers and is thought to contribute to the growth of cancer cells by enhancing the activity of growth-promoting transcription factors, such as c-Myc and β-catenin, and by facilitating RNA metabolism [41,42,43].